Theralase Total Assets from 2010 to 2026

TLT Stock  CAD 0.30  0.02  6.25%   
Theralase Technologies Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2002-03-31
Previous Quarter
M
Current Value
M
Quarterly Volatility
3.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Theralase Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 345.5 K, Interest Expense of 29.1 K or Other Operating Expenses of 4.2 M, as well as many indicators such as Price To Sales Ratio of 67.25, Dividend Yield of 2.16 or PTB Ratio of 37.16. Theralase financial statements analysis is a perfect complement when working with Theralase Technologies Valuation or Volatility modules.
  
This module can also supplement various Theralase Technologies Technical models . Check out the analysis of Theralase Technologies Correlation against competitors.
The evolution of Total Assets for Theralase Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Theralase Technologies compares to historical norms and industry peers.

Latest Theralase Technologies' Total Assets Growth Pattern

Below is the plot of the Total Assets of Theralase Technologies over the last few years. Total assets refers to the total amount of Theralase Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Theralase Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Theralase Technologies' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theralase Technologies' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.25 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Theralase Total Assets Regression Statistics

Arithmetic Mean4,684,221
Geometric Mean3,348,424
Coefficient Of Variation77.67
Mean Deviation2,512,666
Median3,733,991
Standard Deviation3,638,163
Sample Variance13.2T
Range15.3M
R-Value0.28
Mean Square Error13T
R-Squared0.08
Significance0.27
Slope203,890
Total Sum of Squares211.8T

Theralase Total Assets History

20264.4 M
20253.7 M
20243.2 M
20233.3 M
20224.2 M
20215.9 M
202010 M

About Theralase Technologies Financial Statements

Theralase Technologies investors use historical fundamental indicators, such as Theralase Technologies' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theralase Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets3.7 M4.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Theralase Stock Analysis

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.